We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-17.86%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.26B
AUM Growth
-$464M
Cap. Flow
+$97.5M
Cap. Flow %
4.32%
Top 10 Hldgs %
30.92%
Holding
158
New
12
Increased
35
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$50.6M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$28.2M
3
ZGNX
Zogenix, Inc.
ZGNX
+$21.7M
4
TLND
Talend S.A. American Depositary Shares
TLND
+$18.7M
5
TWLO icon
Twilio
TWLO
+$17.9M

Top Sells

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$26.2M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
+$23.3M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$19.7M
4
SLDB icon
Solid Biosciences
SLDB
+$18.9M
5
SNA icon
Snap-on
SNA
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 42.75%
2 Technology 23.08%
3 Consumer Discretionary 10.05%
4 Industrials 6.38%
5 Communication Services 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABB
101
DELISTED
ABB Ltd
ABB
$2.41M 0.11%
127,000
+3,500
+3% +$70.9K
DERM
102
DELISTED
Dermira, Inc.
DERM
$2.4M 0.11%
334,000
– –
FHB icon
103
First Hawaiian
FHB
$3.4B
$2.12M 0.09%
94,000
+1,000
+1% +$24.7K
TSM icon
104
TSMC
TSM
$2.09T
$2.1M 0.09%
57,000
-2,500
-4% -$95.2K
HMC icon
105
Honda
HMC
$39.9B
$2.1M 0.09%
79,500
– –
TERP
106
DELISTED
TerraForm Power, Inc
TERP
$2.02M 0.09%
180,000
– –
GYRE icon
107
Gyre Therapeutics
GYRE
$648M
$1.94M 0.09%
32,800
– –
JCI icon
108
Johnson Controls International
JCI
$87.8B
$1.74M 0.08%
58,500
-3,500
-6% -$115K
ETN icon
109
Eaton
ETN
$150B
$1.66M 0.07%
24,100
– –
MLKN icon
110
MillerKnoll
MLKN
$1.53B
$1.59M 0.07%
52,500
+7,500
+17% +$249K
BG icon
111
Bunge Global
BG
$20.4B
$1.53M 0.07%
28,700
+200
+0.7% +$12.3K
BDN
112
Brandywine Realty Trust
BDN
$525M
$1.47M 0.07%
114,500
– –
CCI.PRA
113
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$1.43M 0.06%
1,355
– –
ARE icon
114
Alexandria Real Estate Equities
ARE
$9.15B
$1.15M 0.05%
10,000
– –
CVA
115
DELISTED
Covanta Holding Corporation
CVA
$1.07M 0.05%
80,000
+1,500
+2% +$23.1K
EPIX
116
DELISTED
ESSA Pharma
EPIX
$1.01M 0.04%
481,970
– –
ERIC icon
117
Ericsson
ERIC
$32.1B
$976K 0.04%
110,000
-12,500
-10% -$109K
VIRX
118
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$942K 0.04%
64,727
– –
GPMT
119
Granite Point Mortgage Trust
GPMT
$64.7M
$883K 0.04%
49,000
-37,500
-43% -$697K
PLD icon
120
Prologis
PLD
$136B
$881K 0.04%
15,000
– –
APU
121
DELISTED
AmeriGas Partners, L.P.
APU
$835K 0.04%
33,000
– –
LXP icon
122
LXP Industrial Trust
LXP
$3.52B
$657K 0.03%
16,000
– –
LPT
123
DELISTED
Liberty Property Trust
LPT
$649K 0.03%
15,500
– –
WELL icon
124
Welltower
WELL
$170B
$521K 0.02%
7,500
-8,600
-53% -$585K
VTR icon
125
Ventas
VTR
$44.7B
$498K 0.02%
8,500
-13,000
-60% -$766K
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Eventide Asset Management held 158 positions worth $2.26B, down 17% from $2.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $97.5M of net new capital in Q4 2018, opening 12 new positions and adding to 35 existing holdings. Its largest new stake was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Macquarie Infrastructure Holdings, LLC, an estimated $19.7M trimmed.

  • Eventide Asset Management's largest Q4 2018 buy was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.
  • Eventide Asset Management added most to Sage Therapeutics in Q4 2018, an estimated $50.6M increase.
  • Eventide Asset Management's biggest Q4 2018 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $19.7M.
  • Eventide Asset Management fully exited AnaptysBio in Q4 2018, selling an estimated $26.2M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $2.26B portfolio in Q4 2018.
  • Eventide Asset Management opened 12 new positions and closed 24 in Q4 2018.
  • Eventide Asset Management's portfolio value fell 17% quarter-over-quarter to $2.26B.

Based on Eventide Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.